Onc Now: Episode 22: Prostate Cancer, Lifestyle, and Equity
Join Stephen Freedland as he explores biology, behaviour, and bias in prostate cancer – covering diet, disparities, and new enzalutamide data
Join Stephen Freedland as he explores biology, behaviour, and bias in prostate cancer – covering diet, disparities, and new enzalutamide data
Sex differences in kidney diseases have received limited attention. Research in this area is crucial for developing targeted prevention…
Discover a study that highlights dupilumab’s consistent efficacy in eosinophilic oesophagitis, even among patients with previous treatment failure or intolerance.
Non-steroidal anti-inflammatory drugs (NSAID) are useful in treating musculoskeletal disorders, headaches, pain, fever, and others…
Inside, you can explore a wide range of content, including our in-depth review of the EULAR 2025 Congress, exclusive interviews with experts…
Discover a study comparing the effectiveness, safety, and tolerability of 39 treatments for moderate to severe hidradenitis suppurativa.
My top priorities as EHA President align closely with the association’s strategic roadmap, which we have developed and begun to implement…
Primary immunodeficiencies (PID) are a heterogeneous group of genetic disorders that render the affected child susceptible to…
Discover a study that proves how a real-time pollen forecasting app can significantly reduce allergy symptoms and improve quality of life.
We are delighted to announce the release of the latest EMJ Hematology issue! Inside, you will find a comprehensive review of the European…
EMJ is delighted to introduce Nicholas Fuggle, Associate Professor in Rheumatology at the University of Southampton, UK, and co-organiser…